Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of IGF-I in HIV Metabolic Disease

This study has been terminated.
Information provided by (Responsible Party):
Roy Kim, University of Texas Southwestern Medical Center Identifier:
First received: April 4, 2011
Last updated: March 22, 2016
Last verified: March 2016
No Study Results Posted on for this Study
  Study Status: This study has been terminated.
  Study Completion Date: June 2013
  Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)